This inventor holds 2 USPTO granted patents. Top assignee: Novo Nordisk A/s. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Praha, CZ (2001)
- Prague, CZ (2001)
Company Filing History:
Years Active: 2001
Title: Zdeněk Polivka: Innovator in Heterocyclic Compounds
Introduction
Zdeněk Polivka is a notable inventor based in Praha, Czech Republic. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds. With a total of 2 patents to his name, Polivka's work has implications in various applications.
Latest Patents
His latest patents include innovative N-substituted azaheterocyclic compounds. The first patent focuses on N-substituted azaheterocyclic compounds of formula I, while the second patent relates to novel N-substituted azaheterocyclic compounds of a general formula. These inventions showcase his expertise and creativity in the field.
Career Highlights
Zdeněk Polivka is currently associated with Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to further his research and development efforts in the pharmaceutical industry.
Collaborations
He has collaborated with esteemed colleagues such as Rolf Hohlweg and Tine Krogh Jørgensen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Zdeněk Polivka's contributions to the field of heterocyclic compounds highlight his role as a significant inventor. His work continues to influence advancements in chemistry and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile